x
Visit our new Mobile Website next time you access NetDania with your mobile device

Y-MABS THERAPEUTICS INC. - COMMON STOCK

11.82
20-19:59:56 GMT
+0.22
+1.90%
ISIN:N/A

Figures - Y-MABS THERAPEUTICS INC. - COMMON STOCK

Open
11.59
Close
11.60
Year Change
73.31
Year % Change
+73.31%
52 Week High
20.90
52 Week Low
4.60
Volume
365847
Inc. Vol
22887

News - Y-MABS THERAPEUTICS INC. - COMMON STOCK

21-13:01 GMT
How To Use Analytics To Buy Your Next Luxury Timepiece
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-13:01 GMT
21-13:01 GMT
The Boston Celtics Cannot Afford To Overlook The Indiana Pacers
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-13:01 GMT
Ariana Grande Matches Justin Bieber With Her Latest No. 1 Hit
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-13:01 GMT
Are Native Ads Going To Be Ruling In Programmatic?
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-13:01 GMT
A Roadmap To Sustainability: Integrating Practices Into Global Supply Chains
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-13:01 GMT
Adobe Lightroom Can Now Remove Background Lurkers With AI
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:57 GMT
Mets Desperately Need Francisco Lindor To Rebound From His Slow Start
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:56 GMT
Zacks Initiates Coverage of Fossil With Neutral Recommendation
Source: NASDAQ Stocks, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:56 GMT
Air Products (APD) Up 15% in 3 Months: What's Driving the Stock?
Source: NASDAQ Stocks, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:56 GMT
Eagle Materials (EXP) Misses Q4 Earnings and Revenue Estimates
Source: NASDAQ Stocks, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:56 GMT
Flexible Solutions (FSI) Q1 Earnings and Sales Lag Estimates
Source: NASDAQ Stocks, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:56 GMT
Halliburton (HAL) Invites Africa's Companies to Submit EOIs
Source: NASDAQ Stocks, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:56 GMT
How to Buy MRVL for an 8% Discount, or Achieve a 90% Annual Return
Source: NASDAQ Stocks, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
ADBE Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
JPM Quantitative Stock Analysis - Peter Lynch
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
QCOM Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
INTC Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
V Quantitative Stock Analysis - Warren Buffett
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
CRM Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
COST Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
BAC Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
BA Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
BABA Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
PDD Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
MARA Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
CVX Quantitative Stock Analysis - Peter Lynch
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
DELL Quantitative Stock Analysis - Peter Lynch
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:55 GMT
WMT Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:52 GMT
Transformative Projects And Acquisitions Shape Masdar’s Renewable Energy Strategy, Says COO
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:51 GMT
How Tiana Tukes Is Changing Classrooms And Venture Capital
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:47 GMT
Will Medtronic Stock See Higher Levels Post Q4 Results After 5% Gains This Year?
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:47 GMT
How To Overcome Integration Challenges In Accounts Payable Software
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:47 GMT
Breaking Down The AI/GenAI Landscape And Solution Approaches
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:46 GMT
An Update On ‘Yellowstone’ Season 5 Part 2’s Release Date
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:43 GMT
INDAY: Striving To Be A Major Fast-Casual Indian Restaurant Chain
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:37 GMT
What Makes An Innovative Team?
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:36 GMT
Amber Rose Endorses Trump: Here’s Other Celebrities Who Have Switched Sides Or Won’t Endorse A Candidate
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:36 GMT
AI Might Be Smarter Than Your CMO
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
21-12:31 GMT
How AI Will Empower Citizen Developers And Streamline Operations
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
39796.42
-19.67
-0.05%
5305.64
-7.07
-0.13%
18631.93
-40.19
-0.22%
71236.00
-192
-0.27%
18680.93
-74.93
-0.40%
38890.50
-337.43
-0.86%
3157.97
-13.18
-0.42%
8393.53
-11.88
-0.14%
19165.43
-353.57
-1.81%
7837.14
-12.58
-0.16%
22529.05
62.95
0.28%
2421.67
-4.45
-0.18%
82.59
-1.063
-1.27%
1.08435
-0.00167
-0.15%
156.409
0.009
0.01%
1.26886
-0.00209
-0.16%
0.66592
-0.00123
-0.18%
1.36754
0.00519
0.38%
169.59900
-0.256
-0.15%
0.85456
0.00008
0.01%
198.46000
-0.319
-0.16%
0.91122
0.00107
0.12%
0.98809
-0.00035
-0.04%
0.60892
-0.00173
-0.28%
104.62300
-0.001
0.00%
Top Gainers
Name
Last
+/-
%
0.09
0.06
187.25%
7.80
4.68
150.00%
1.33
0.74
125.12%
0.19
0.08
80.27%
1.80
0.77
74.76%
0.17
0.07
67.85%
3.85
1.55
67.39%
1.71
0.59
52.68%
1.34
0.44
48.89%
1.53
0.50
48.54%
Top Losers
Name
Last
+/-
%
1.05
-5.96
-85.02%
0.16
-0.20
-55.64%
0.01
-0.01
-52.20%
0.78
-0.77
-49.87%
0.20
-0.15
-43.94%
0.01
-0.01
-40.82%
0.38
-0.26
-40.68%
0.01
0.00
-38.89%
0.05
-0.03
-37.69%
0.03
-0.02
-35.75%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy